Free Trial
NASDAQ:BIS

ProShares UltraShort Nasdaq Biotechnology (BIS) Price, Holdings, & News

$18.26 -0.27 (-1.46%)
(As of 12/20/2024 05:15 PM ET)

About ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS)

Key Stats

Today's Range
$17.92
$18.39
50-Day Range
$14.35
$18.53
52-Week Range
$14.05
$21.10
Volume
14,382 shs
Average Volume
14,141 shs
Market Capitalization
$4.02 million
Assets Under Management
$4.05 million
Dividend Yield
2.57%
Net Expense Ratio
0.95%
Aggregate Rating
N/A

ETF Overview

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

ProShares UltraShort Nasdaq Biotechnology Expenses

TypeBISHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.75%0.57%0.55%0.50%0.52%
Other Expenses1.22%0.30%0.49%0.41%0.53%
Total Expense1.97%0.70%0.71%0.64%0.71%
Fee Waiver-1.02%-0.45%-0.51%-0.31%-0.56%
Net Expense0.95%0.61%0.61%0.57%0.59%
Receive BIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

BIS ETF News Headlines

BIS ProShares UltraShort Nasdaq Biotechnology ETF
Why I'm telling friends to avoid gold stocks
Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."
Investing Strategies for Market Crashes
See More Headlines

BIS ETF - Frequently Asked Questions

ProShares UltraShort Nasdaq Biotechnology's stock was trading at $18.07 at the beginning of the year. Since then, BIS stock has increased by 1.1% and is now trading at $18.26.
View the best growth stocks for 2024 here
.

ProShares UltraShort Nasdaq Biotechnology shares reverse split on Tuesday, August 18th 2020. The 1-4 reverse split was announced on Tuesday, August 4th 2020. The number of shares owned by shareholders was adjusted after the market closes on Monday, August 17th 2020. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Top institutional investors of ProShares UltraShort Nasdaq Biotechnology include Jane Street Group LLC (4.78%).
View institutional ownership trends
.

Shares of BIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that ProShares UltraShort Nasdaq Biotechnology investors own include Micron Technology (MU), Inovio Pharmaceuticals (INO), Sanofi (SNY), Intel (INTC), Meta Platforms (META), NVIDIA (NVDA) and Advanced Micro Devices (AMD).

Fund Details

Issuer
ProShares
Fund Name
ProShares UltraShort Nasdaq Biotechnology
Tax Classification
Regulated Investment Company
Current Symbol
NASDAQ:BIS
Inception Date
4/6/2010
Fund Manager
Michael Neches, Tarak Dave

Fund Focus

Asset Class
Equity
Benchmark
Nasdaq Biotech Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
16

Fund Statistics

Assets Under Management
$4.05 million
Average Daily Volume
$14,929.30
Discount/Premium
0.04%
Leveraged
-2.00

Administrator, Advisor and Custodian

Administrator
J.P. Morgan Investor Services Co.
Advisor
ProShare Advisors LLC
Custodian
JPMorgan Chase Bank, N.A.
Distributor
SEI Investments Distribution Co.
Transfer Agent
JPMorgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
1
Put Options
2
Call Options
1
Short Interest
8,400 shs

Miscellaneous

Beta
-1.41
Creation Unit
50,000
Creation Fee
$250.00
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Top 8 BIS Holdings

  • NET OTHER ASSETS (LIABILITIES)
    Holding Weight: 0.00%
  • TREASURY BILL
    Holding Weight: 0.00%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA
    Holding Weight: -7.73%
  • NASDAQ BIO INDEX SWAP BNP PARIBAS
    Holding Weight: -12.70%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC
    Holding Weight: -15.06%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA
    Holding Weight: -20.56%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG
    Holding Weight: -68.23%
  • NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE
    Holding Weight: -75.69%

This page (NASDAQ:BIS) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners